Evaluation of a spot-on imidacloprid-moxidectin formulation (Advocate®) for the treatment of naturally occurring esophageal spirocercosis in dogs: a double-blinded, placebo-controlled study

Evaluation of a spot-on imidacloprid-moxidectin formulation (Advocate®) for the treatment of naturally occurring esophageal spirocercosis in dogs: a double-blinded, placebo-controlled study

Abstract Background Dogs are the definitive hosts of Spirocerca lupi. Spirocercosis is treated by prolonged avermectin administration by injection or daily oral doses. In this prospective, double-blinded, placebo-controlled, clinical trial, the efficacy of imidacloprid and moxidectin spot-on formula...

Full description

Bibliographic Details
Main Authors: Gilad Segev, Alicia Rojas, Eran Lavy, Marganit Yaffe, Itamar Aroch, Gad Baneth
Format: Article
Language:English
Published: BMC 2018-03-01
Series:Parasites & Vectors
Subjects:
Canine
Spirocerca lupi
Esophagus
Doramectin
Endoscopy
Coproscopy
Online Access:http://link.springer.com/article/10.1186/s13071-018-2731-x

Internet

http://link.springer.com/article/10.1186/s13071-018-2731-x

Similar Items